Pharmacological treatment of portal hypertension

Prog Liver Dis. 1995;13:269-92.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Catheterization
  • Clinical Trials as Topic
  • Diuretics / therapeutic use
  • Esophageal and Gastric Varices / drug therapy
  • Gastrointestinal Hemorrhage / drug therapy
  • Humans
  • Hypertension, Portal / drug therapy*
  • Hypertension, Portal / therapy
  • Lypressin / analogs & derivatives
  • Lypressin / therapeutic use
  • Metoclopramide / therapeutic use
  • Molsidomine / therapeutic use
  • Octreotide / therapeutic use
  • Portasystemic Shunt, Surgical
  • Sclerotherapy
  • Somatostatin / therapeutic use
  • Terlipressin
  • Vasodilator Agents / therapeutic use
  • Vasopressins / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Diuretics
  • Vasodilator Agents
  • Vasopressins
  • Lypressin
  • Somatostatin
  • Terlipressin
  • Molsidomine
  • Metoclopramide
  • Octreotide